Treatment of cutaneous lymphoid hyperplasia with thalidomide: report of two cases.
Cutaneous benign lymphoid hyperplasia is a B-cell pseudolymphoma of unknown origin. The most favored sites of involvement include the face. We report two cases involving the nose that showed complete and stable regression after a 2-month treatment course with thalidomide.
Benchikhi
H
H
Department of Dermatology, Hôpital Henri Mondor, Créteil, France.
Bodemer
C
C
Fraitag
S
S
Wechsler
J
J
Delfau-Larue
M H
MH
Gounod
N
N
de Prost
Y
Y
Revuz
J
J
Bagot
M
M
D000293:Adolescent; D000328:Adult; D001402:B-Lymphocytes; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005148:Facial Dermatoses / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D009666:Nose; D019310:Pseudolymphoma / Q000188:drug therapy* / Q000473:pathology; D013792:Thalidomide / Q000627:therapeutic use*
D003879:Dermatologic Agents; D013792:Thalidomide